维生素B3衍生物支持胰腺癌细胞存活率和抗化疗能力
Faith Nakazzi1, Mehrdad Zarei2, Mariana Lopes3
1Department of Biochemistry, Case Western Reserve University, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH.
Cancer letters
|February 22, 2026
概括
尼古丁胺胺氨基二核酸 (NAD+) 前体如NMN可能会保护癌细胞,降低化疗的有效性. 维生素B3衍生物可以支持瘤生长,突出显示使用这些补充剂的癌症患者的风险.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 营养学科学 营养学科学
背景情况:
- 尼古丁胺胺二核酸 (NAD+) 对于细胞功能至关重要.
- NAD+前体 (NAM,NR,NMN) 是受欢迎的补充剂,具有潜在的健康益处.
- 它们在癌症和化疗中的作用尚未完全理解.
研究的目的:
- 研究NAD+前体 (NAM,NR,NMN) 对胰腺管腺癌 (PDAC) 化疗疗效能的影响.
- 探索这些补充剂影响癌细胞和瘤进展的机制.
主要方法:
- 在体外研究中,使用PDAC细胞系治疗了化疗剂.
- 在免疫能力和免疫缺陷的小鼠模型中的体内研究与NAD+前体补充.
- 评估癌细胞存活率,DNA损伤,亡,线粒体功能和瘤生长.
主要成果:
- 通过NMN,可以显著地保护癌细胞免受常见化学疗法 (oxaliplatin,5-FU,gemcitabine) 的影响.
- NAD+前体增强了线粒体功能,减少了氧化应激,并抑制了癌细胞中的DNA损伤和亡.
- 用NAM和NMN补充促进了化疗耐药性,并在小鼠模型中支持瘤生长.
结论:
- 增强NAD+的补充剂,特别是NMN,可以赋予PDAC细胞的化疗耐药性.
- 这些维生素B3衍生物可能促进瘤细胞的存活,并损害癌症患者的治疗疗效.
- 建议在癌症患者中使用NAD+前体时谨慎使用,特别是那些接受PDAC化疗的人.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
678
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
678
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
830
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
830
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
962
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
962
01:15Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K